IPO
More news about this topic
-
VC ExitsSpaceX’s tiered IPO lockup aims to build a ladder, not a cliff
May 26, 2026It’s the biggest IPO ever, and with unique circumstances putting extra pressure on its stock price, SpaceX is hoping to smooth it out through its lockup structure.Article
Learn more » -
IPOA deleted disclosure in SpaceX’s S-1 reveals the real economics of its AI infrastructure
May 23, 2026SpaceX could recoup its AI infrastructure capex in under a monthArticle
Learn more » -
AI & ML‘Financials look reckless': Lifting the xAI hood in the SpaceX IPO
May 20, 2026The Grok-maker’s losses are accelerating as SpaceX’s IPO pulls back the curtain for the first time on the financials of a large AI model company.Article
Learn more » -
IPOLincoln International rises 12% in NYSE debut
May 20, 2026The investment bank’s decision to go public—after more than 30 years without taking any outside equity—came down to good timing, CEO Robert Brown told PitchBook.Article
Learn more » -
VC ExitsSpaceX files for its historic IPO
May 20, 2026Investors are closely watching its Starlink revenue, as well as the xAI integration.Article
Learn more » -
FintechKikoff co-founder alleges CEO froze IPO plans, pressured him into discounted secondary sale
May 19, 2026The legal dispute highlights the internal issues that can arise as companies remain private longer.Article
Learn more » -
IPOCerebras’ blockbuster public listing sets stage for AI IPO frenzy
May 14, 2026The chipmaker priced well above its initial range at $185, and opened trading at an eye-popping $350.Article
Learn more » -
VC ExitsFervo rides data center energy boom with 35% IPO pop
May 13, 2026The energy startup, which develops next-generation geothermal technology, raised $1.89 billion in its upsized IPO.Article
Learn more » -
Analyst NotePitchBook Analyst Note: SPACs at VC’s Gate
May 11, 2026SPACs return after a 75% deSPAC index decline. The 2024 SEC overhaul tightened the rules, but with 25% of unicorns stalled since 2022, whether discipline follows structure remains the open question.Research
Learn more » -
IPOE-scooter rental company Lime files for IPO as debt maturities loom
May 8, 2026The scooter rental industry has struggled for years, despite massive early VC support—Lime is a rare survivorArticle
Learn more » -
Private EquityLeonard Green’s Sokoloff warns against holding on to companies too long
May 5, 2026Most LPs are compensated based on IRR, making the length of the hold period as important as the overall return, he said.Article
Learn more » -
Public-Private ConvergencePershing Square USA’s first-day stock performance is an early sign of the challenges ahead
April 29, 2026Shares in Bill Ackman’s new $5B investment vehicle dropped 18.2%, highlighting a common mismatch between the asset value of such vehicles and their market price.Article
Learn more » -
Limited PartnersAmazon-backed X-Energy surges 27% in Nasdaq debut
April 24, 2026The nuclear reactor developer canceled a de-SPAC listing in 2023.Article
Learn more » -
VC2026’s fast-approaching mega-IPO wave is expected to reset the VC secondaries market
April 22, 2026Top IPO contenders SpaceX, OpenAI and Anthropic are also some of the most traded stocks in the secondary markets.Article
Learn more » -
Limited PartnersIPO activity is roaring back, but only in certain sectors
April 21, 2026Biotech and healthcare are leading April’s IPO resurgence, headlined by Kailera Therapeutics’ record $625 million debut. For tech startups, it’s still mostly wait-and-see.Article
Learn more » -
IPOBreaking down AI chipmaker Cerebras’ S-1
April 17, 2026From the major UAE revenue portion to special agreements with OpenAI, here’s what you need to know about the Nvidia rival’s IPO filing.Article
Learn more » -
StartupsEmployees at mega-IPO candidates are opting out of tender offers in a ‘champagne problem’
April 17, 2026Anthropic’s recent tender offer fell short of its $6B target, an investor in the company said.Article
Learn more » -
VC ExitsBiotech IPOs poised for a comeback—but only for some
April 15, 2026A GLP-1 maker and a protein biomarker detection company are the latest to head for biotech IPOs. M&A activity is helping bolster that.Article
Learn more »